UnitedHealth Group Inc (NYSE:UNH) shares closed Tuesday’s session lower following a Bloomberg report suggesting a U.S. Department of Justice criminal probe into the company is broader than previously known, according to people familiar with the matter.
What To Know: Per Bloomberg, the investigation is now scrutinizing business practices at the company’s pharmacy benefit manager, Optum Rx, as well as payments to its physicians. This newly revealed scope is in addition to an ongoing criminal investigation by the department’s fraud unit into UnitedHealth’s Medicare Advantage billing practices.
